Prevalence and spectrum of in utero structural brain abnormalities in fetuses with complex congenital heart disease

M Brossard-Racine1, A J du Plessis2, G Vezina3

  • 1From the Advanced Pediatric Brain Imaging Research Laboratory (M.B.-R., I.E.E., D.F., C.L.)Division of Diagnostic Imaging and Radiology (M.B.-R., G.V., D.B., I.E.E., D.F., C.L.)Fetal and Transitional Medicine (M.B.-R., A.d.P., M.D., C.L.).

Insights

Brain abnormalities are common in fetuses with congenital heart disease (CHD). This study found 23% of fetuses with CHD had brain abnormalities, compared to only 1.5% in healthy controls.

Area of Science:

  • Neonatal neurology
  • Fetal imaging
  • Congenital heart disease

Background:

  • Brain injury is a significant complication for neonates with complex congenital heart disease (CHD).
  • Fetuses with CHD may have an increased risk of brain abnormalities.
  • Previous studies have not prospectively examined the nature and frequency of these abnormalities using conventional fetal MRI.

Purpose of the Study:

  • To determine the prevalence and spectrum of brain abnormalities in fetuses with complex CHD using conventional fetal MRI.
  • To compare the prevalence of brain abnormalities in fetuses with CHD to a control group of fetuses from healthy pregnancies.

Main Methods:

  • Prospective recruitment of pregnant women with confirmed fetal CHD and healthy controls.
  • Fetal MRI performed between 18 and 39 weeks of gestational age.
  • Comparison of brain abnormality findings between the CHD cohort (144 fetuses) and the control group (194 fetuses).

Main Results:

  • Brain abnormalities were detected in 23% of fetuses with CHD, versus 1.5% in controls (P < .001).
  • The most frequent abnormalities in the CHD group were mild unilateral ventriculomegaly (36.4%) and increased extra-axial spaces (30.3%).
  • No significant association was found between specific cardiac physiology and the type or frequency of brain abnormalities.

Conclusions:

  • This is the first large prospective study to report conventional MRI findings in fetuses with CHD.
  • Brain abnormalities are prevalent but generally mild in fetuses with CHD.
  • Further research is needed to understand the long-term implications of these antenatal findings.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.0K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.9K
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
699